We measured the financial consequences of new CRC treatment regimens. New regimens have increased cost directly through price and indirectly through nonstandard and second-line regimen use.
Holly Van Houten, BA
Advertisement
Articles by Holly Van Houten, BA
Advertisement
Latest Updated Articles
- Impact of New Drugs and Biologics on Colorectal Cancer Treatment and Costs
Published: May 17th 2011 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
FDA Expands Evinacumab-dgnb Approval for Children as Young as 1 Year With HoFH
2
In Primary Care–Oncology Collaboration, the Baton Goes Both Ways
3
FDA Approves Imlunestrant for ER+ and HER2-Negative Breast Cancer
4
US, Japan Patients With Diabetes Discontinue Semaglutide After First Year
5
